BEACON THERAPEUTICS LIMITED
Get an alert when BEACON THERAPEUTICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£4M
USD 5,358,803
+186.7% highest in 3 filed years
Net assets
£28M
USD 37,961,166
-26.2% lowest in 3 filed years
Employees
15
+7.1% highest in 3 filed years
Profit before tax
-£79M
USD -105,507,306
-56.5% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The Company has sustained recurring net losses... and is reliant on funding from the group headed by Beacon Therapeutics Holdings Limited ("the Group"), which has a material uncertainty in relation to the going concern. There is a material uncertainty related to the Tranche 2 clinical milestone.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | -£43,755,548 | -£50,281,866 | -£78,823,707 | -56.8% | |
| Profit before tax | -£42,254,901 | -£50,481,732 | -£78,984,358 | -56.5% | |
| Net profit | -£41,039,229 | -£48,570,880 | -£76,239,519 | -57% | |
| Cash | £858,974 | £1,399,163 | £4,011,681 | +186.7% | |
| Total assets less current liabilities | £40,601,457 | £40,315,371 | £30,965,947 | -23.2% | |
| Net assets | £37,549,669 | £38,530,917 | £28,418,301 | -26.2% | |
| Equity | £37,549,669 | £38,530,917 | £28,418,301 | -26.2% | |
| Average employees | 8 | 14 | 15 | +7.1% | |
| Wages | £1,060,677 | £1,656,048 | £1,976,892 | +19.4% | |
| Directors' remuneration | — | £198,533 | £264,853 | +33.4% |
Figures converted to GBP from USD at 0.749 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | -107.8% | -124.7% | -254.5% | |
| Gearing (liabilities / total assets) | 31.8% | 13.9% | — | |
| Current ratio | 0.23x | 1.48x | 0.64x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- BEACON THERAPEUTICS LIMITED 2023-06-01 → present
- ALLIANCE HOLDCO LIMITED 2022-10-18 → 2023-06-01
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The Company has sustained recurring net losses... and is reliant on funding from the group headed by Beacon Therapeutics Holdings Limited ("the Group"), which has a material uncertainty in relation to the going concern. There is a material uncertainty related to the Tranche 2 clinical milestone.”
Group structure
- BEACON THERAPEUTICS LIMITED · parent
- Beacon Therapeutics (USA), Inc. 100%
Significant events
- “On 2 January 2026, Beacon Therapeutics Holdings Limited completed Series C Fund raising of $75m. $38.3m of this funding was received in advance in December 2025 and $2.7m was received in January 2026 with the balance expected to be received in the fourth quarter of 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BALDO, Lance | Director | 2024-09-27 | Oct 1972 | American |
| RIGBY, Benjamin Thomas | Director | 2024-01-17 | Sep 1975 | British |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FELLOWS, David Andrew | Director | 2023-02-01 | 2024-09-27 |
| HOLLOWOOD, Christopher John, Dr | Director | 2022-10-18 | 2024-01-18 |
| PETRIS, Elisa Michela, Dr | Director | 2022-10-18 | 2024-01-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Beacon Therapeutics Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-03-06 | Active |
Filing timeline
Last 20 of 31 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-06-10 MA Memorandum articles
- 2023-06-10 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-15 | AA | accounts | Accounts with accounts type full | |
| 2025-12-08 | SH01 | capital | Capital allotment shares | |
| 2025-10-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-06-13 | SH01 | capital | Capital allotment shares | |
| 2025-06-06 | AA | accounts | Accounts with accounts type full | |
| 2024-12-18 | SH01 | capital | Capital allotment shares | |
| 2024-10-30 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-16 | AA | accounts | Accounts with accounts type full | |
| 2024-10-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-14 | SH01 | capital | Capital allotment shares | |
| 2024-01-23 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-23 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-23 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-20 | SH01 | capital | Capital allotment shares | |
| 2023-10-17 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-08-08 | SH01 | capital | Capital allotment shares | |
| 2023-08-02 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-06-10 | MA | incorporation | Memorandum articles | |
| 2023-06-10 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.